PiyushKumarAgarwalMD

Urology • Chicago, IL

Surgical Oncology

Director of the Bladder Cancer Program Professor of Surgery in the Section of Urology The University of Chicago Medicine

Join to view full profile

Dr. Agarwal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Agarwal's full profile

Already have an account?

Office
5841 S. MARYLAND
M/C 6038
Chicago, IL 60637
Phone+1 773-702-3080

Summary

Dr. Piyush Agarwal is an urologist in Chicago, IL and is affiliated with University of Chicago Medical Center. He received his medical degree from Weill Cornell Medicine and has been in practice 17 years. He also speaks multiple languages, including French, Hindi, and Urdu. He specializes in surgical oncology and is experienced in urologic oncology and bladder cancer. He has more than 100 publications and over 500 citings.

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2006 - 2008
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Urology, 2002 - 2006
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Surgery, 2000 - 2002
Weill Cornell MedicineClass of 2000

Certifications & Licensure

DE State Medical License Current
IL State Medical License 2019 - 2026
IN State Medical License 2023 - 2025
PA State Medical License 2012 - 2021
MD State Medical License 2014 - 2020
VA State Medical License 2018 - 2020
MI State Medical License 2008 - 2015
OH State Medical License 2000 - 2009
TX State Medical License 2006 - 2009
American Board of Urology Urology
Join now to see all

Clinical Trials

Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCG Start of enrollment: 2013 Dec 18
Completed
Phase 2
Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG) Start of enrollment: 2018 Jun 07
Completed
Phase 1
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer Start of enrollment: 2022 Mar 01
Active, not recruiting
Phase 3
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

Trends in the use of immediate postoperative intravesical chemotherapy following transurethral resection of bladder tumors.
Aaron S Dahmen, David J Nusbaum, Alon Lazarovich, Jared Fialkoff, Parth K Modi
Urologic Oncology. 2025-01-01
The impact of metabolic syndrome on short term radical cystectomy complications.
Aaron S Dahmen, Alon Lazarovich, David J Nusbaum, Behdod Katebian, Parth Modi
Urologic Oncology. 2024-12-01
Urologic oncology case volume among early career urologists: An analysis of certification data from the American board of urology between 2003 and 2019.
Devki Shukla, Max J Hyman, Piyush K Agarwal, Sarah Faris, Ted A Skolarus
Urologic Oncology. 2024-10-10

Press Mentions

What the Color of Your Pee Can Tell You About Your HealthJanuary 30th, 2021
What the Smell of Your Pee Can Tell You About Your HealthJanuary 23rd, 2021
ODAC Cautiously Backs Keytruda in Early Bladder CancerDecember 17th, 2019
Join now to see all

Other Languages

French, Hindi, Urdu